55.00
+0.50
+(0.92%)
At close: January 31 at 5:25:14 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-103,769.00
-50,222.00
-59,862.00
-33,254.00
-45,076.00
Investing Cash Flow
-45.00
--
-29.00
-12.00
9,710.00
Financing Cash Flow
180,634.00
92,869.00
140,818.00
-6,117.00
192,343.00
End Cash Position
334,186.00
271,772.00
227,827.00
148,380.00
187,986.00
Income Tax Paid Supplemental Data
279.00
1,245.00
120.00
1.00
8.00
Interest Paid Supplemental Data
7,230.00
2,006.00
348.00
215.00
7.00
Capital Expenditure
--
--
-29.00
-12.00
-82.00
Issuance of Capital Stock
--
56,909.00
149,797.00
733.00
200,156.00
Issuance of Debt
251,212.00
38,708.00
10,000.00
--
5,000.00
Repayment of Debt
-52,256.00
--
-5,000.00
--
--
Free Cash Flow
-103,814.00
-50,222.00
-59,891.00
-33,266.00
-45,158.00
12/31/2020 - 9/24/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
12X1.F Anavex Life Sciences Corp.
9.11
-0.87%
0QF.DE Moderna, Inc.
39.44
-2.17%
22UA.DE BioNTech SE
118.40
-0.17%
NAMS NewAmsterdam Pharma Company N.V.
22.29
+2.39%
AVXL Anavex Life Sciences Corp.
9.27
-3.13%
AXSM Axsome Therapeutics, Inc.
106.46
-2.20%
CRSP CRISPR Therapeutics AG
41.59
-1.07%
VRTX Vertex Pharmaceuticals Incorporated
461.68
+5.31%